About Formycon AG
Formycon AG | 2,275 followers on LinkedIn. Global Quality Biosimilars | Who we are?
Formycon is a leading, independent developer of high-quality biopharmaceutical medicines, especially biosimilars. The company focuses on treatments in ophthalmology, immunology and on other key chronic diseases, covering the entire value chain from technical development to the clinical phase III as well as the preparation of dossiers for marketing approval.
|
|
|
51-200 employees
View all Formycon AG employees
|
|
Biotechnology
|
|
Fraunhoferstrasse 15, Planegg, BY 82152, DE
|
|
2012
|
|
Quality Management, Project Management, Ophthalmology, Immunology, Device Development, Drug Product, Biosimilar Development, Scientific Professionals, Biosimilar Medicines, Cmc Regulatory Affairs, Cmc With Strong Analytics, Certified Gmp Analytical Laboratory, Preclinical & Bioanalytics, Anti Body Based Covid-19 Drugs
|
Formycon AG Alternatives
Frequently Asked Questions about Formycon AG
Carsten Brockmeyer is the CEO of Formycon AG. To contact Carsten Brockmeyer email at [email protected].
Formycon AG Staff Directory
Search Formycon AG Staff Directory
Find accurate personal emails, work emails and phone numbers for employees
Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut
Find countless prospects outside of LinkedIn fast
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.
